Comment
. 2004 May 8;328(7448):1135; author reply 1136.
doi: 10.1136/bmj.328.7448.1135-a.
Turning a blind eye: testing the success of blinding and the CONSORT statement
- PMID: 15130995
- PMCID: PMC406363
- DOI: 10.1136/bmj.328.7448.1135-a
Item in Clipboard
Comment
Turning a blind eye: testing the success of blinding and the CONSORT statement
BMJ.
.
No abstract available
Comment on
-
Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.BMJ. 2004 Feb 21;328(7437):432. doi: 10.1136/bmj.37952.631667.EE. Epub 2004 Jan 22. BMJ. 2004. PMID: 14761905 Free PMC article. Review.
Similar articles
-
Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials.BMJ. 2004 Feb 21;328(7437):432. doi: 10.1136/bmj.37952.631667.EE. Epub 2004 Jan 22. BMJ. 2004. PMID: 14761905 Free PMC article. Review.
-
Who is blinded in randomized clinical trials? A study of 200 trials and a survey of authors.Clin Trials. 2006;3(4):360-5. doi: 10.1177/1740774506069153. Clin Trials. 2006. PMID: 17060210 Review.
-
The blind leading the blind: use and misuse of blinding in randomized controlled trials.Contemp Clin Trials. 2011 Mar;32(2):240-3. doi: 10.1016/j.cct.2010.11.004. Epub 2010 Nov 9. Contemp Clin Trials. 2011. PMID: 21070890
-
Blinding in randomized clinical trials: imposed impartiality.Clin Pharmacol Ther. 2011 Nov;90(5):732-6. doi: 10.1038/clpt.2011.207. Epub 2011 Oct 12. Clin Pharmacol Ther. 2011. PMID: 21993424
-
Blinded trials taken to the test: an analysis of randomized clinical trials that report tests for the success of blinding.Int J Epidemiol. 2007 Jun;36(3):654-63. doi: 10.1093/ije/dym020. Epub 2007 Apr 17. Int J Epidemiol. 2007. PMID: 17440024
Cited by
-
Assessment of blinding to treatment allocation in studies of a cannabis-based medicine (Sativex®) in people with multiple sclerosis: a new approach.Trials. 2012 Oct 9;13:189. doi: 10.1186/1745-6215-13-189. Trials. 2012. PMID: 23046749 Free PMC article.
-
Reporting methods of blinding in randomized trials assessing nonpharmacological treatments.PLoS Med. 2007 Feb;4(2):e61. doi: 10.1371/journal.pmed.0040061. PLoS Med. 2007. PMID: 17311468 Free PMC article. Review.
-
A review of 17 years of application of partnership care model on the consequences of chronic diseases: Describing and assessing the quality of the methodology of papers.Med J Islam Repub Iran. 2020 Feb 18;34:7. doi: 10.34171/mjiri.34.7. eCollection 2020. Med J Islam Repub Iran. 2020. PMID: 32284931 Free PMC article. Review.
-
Research designs for proof-of-concept chronic pain clinical trials: IMMPACT recommendations.Pain. 2014 Sep;155(9):1683-1695. doi: 10.1016/j.pain.2014.05.025. Epub 2014 May 24. Pain. 2014. PMID: 24865794 Free PMC article. Review.
-
Objectifying specific and nonspecific effects of acupuncture: a double-blinded randomised trial in osteoarthritis of the knee.Evid Based Complement Alternat Med. 2013;2013:427265. doi: 10.1155/2013/427265. Epub 2013 Jan 10. Evid Based Complement Alternat Med. 2013. PMID: 23365608 Free PMC article.
References
-
- Moher D, Schulz KF, Altman DG for the CONSORT Group. The CONSORT statement: revised recommendations for improving the quality of reports of parallel-group randomised trials. Lancet 2001;357: 1191-4. - PubMed
-
- Schulz KF, Chalmers I, Altman DG. The landscape and lexicon of blinding in randomized trials. Ann Intern Med 2002;136: 254-9. - PubMed
-
- Schulz KF, Grimes DA. Blinding in randomised trials: hiding who got what. Lancet 2002;359: 696-700. - PubMed
-
- Altman DG, Schulz KF, Moher D, Egger M, Davidoff F, Elbourne D, et al. The revised CONSORT statement for reporting randomized trials: explanation and elaboration. Ann Intern Med 2001;134: 663-94. - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
